Wed, February 3, 2021

Michelle Gilson Maintained (TVTX) at Strong Buy with Increased Target to $51 on, Feb 3rd, 2021

Michelle Gilson of Canaccord Genuity, Maintained "Travere Therapeutics, Inc." (TVTX) at Strong Buy with Increased Target from $28 to $51 on, Feb 3rd, 2021.

Michelle, nor any peers, have made any analyst calls on TVTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30